Charité Biomedical Fund (Charité Beteiligungsfonds)

Peppermint Management GmbH and Stiftung Charité are launching the Charité Biomedical Fund (CBF), an independent venture capital fund investing in start-ups and young companies in the healthcare sector having shown first “proof of concept”. CBF will build a portfolio of promising medtech, biotech, and healthcare service companies. The Charité Biomedical Fund will be managed by the Managing Partners of Peppermint with a track record in building early stage life science companies.

Managed by        Cooperating with 
 


Contact

Peppermint Venture Partners GmbH

Ingeborg Neumann
Dr. Joachim Rautter
Dr. Klaus Stöckemann
Managing Partners
T: +49 (0)30-59 00 64-430


in (at) peppermint-vp.com

jr (at) peppermint-vp.com

ks (at) peppermint-vp.com